180 related articles for article (PubMed ID: 35653138)
1. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
[TBL] [Abstract][Full Text] [Related]
2. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus Vaccination as an Adjuvant Therapy for Recurrent Respiratory Papillomatosis: Additional Case Series.
Matsuzaki H; Makiyama K; Hasegawa H; Asai R; Morita M; Oshima T
J Voice; 2024 Jan; 38(1):204-209. PubMed ID: 34600799
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
Nyirjesy S; Osmundson P; Matrka L
J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
Chirilă M; Bolboacă SD
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1135-42. PubMed ID: 24121781
[TBL] [Abstract][Full Text] [Related]
6. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
Yiu Y; Fayson S; Smith H; Matrka L
Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
[TBL] [Abstract][Full Text] [Related]
7. [Recurrent respiratory papillomatosis: indication for HPV vaccination?].
Pawlita M; Gissmann L
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S100-2. PubMed ID: 19353471
[TBL] [Abstract][Full Text] [Related]
8. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
Bertino G; Pedretti F; Mauramati S; Filauro M; Vallin A; Mora F; Crosetti E; Succo G; Peretti G; Benazzo M
Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S111-S122. PubMed ID: 37698108
[TBL] [Abstract][Full Text] [Related]
9. Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.
Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
Clin Exp Immunol; 2020 Feb; 199(2):131-142. PubMed ID: 31628850
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis.
Ponduri A; Azmy MC; Axler E; Lin J; Schwartz R; Chirilă M; Dikkers FG; Yang CJ; Mehta V; Gangar M
Laryngoscope; 2023 Sep; 133(9):2046-2054. PubMed ID: 36651338
[TBL] [Abstract][Full Text] [Related]
11. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
[TBL] [Abstract][Full Text] [Related]
12. Human papilloma virus (HPV) vaccination is associated with reduced number of surgical treatments, an observational study on recurrent respiratory papillomatosis in Northern Sweden.
Schindele A; Al-Sabtti S; Olofsson K
Acta Otolaryngol; 2024 Jan; 144(1):71-75. PubMed ID: 38484282
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.
Sullivan C; Curtis S; Mouzakes J
Int J Pediatr Otorhinolaryngol; 2017 Feb; 93():103-106. PubMed ID: 28109479
[TBL] [Abstract][Full Text] [Related]
14. Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.
Stratton P; Battiwalla M; Tian X; Abdelazim S; Baird K; Barrett AJ; Cantilena CR; Childs RW; DeJesus J; Fitzhugh C; Fowler D; Gea-Banacloche J; Gress RE; Hickstein D; Hsieh M; Ito S; Kemp TJ; Khachikyan I; Merideth MA; Pavletic SZ; Quint W; Schiffman M; Scrivani C; Shanis D; Shenoy AG; Struijk L; Tisdale JF; Wagner S; Williams KM; Yu Q; Wood LV; Pinto LA
JAMA Oncol; 2020 May; 6(5):696-705. PubMed ID: 32105293
[TBL] [Abstract][Full Text] [Related]
15. In RRP, serologic response to HPV is frequently absent and slow to develop.
Buchinsky FJ; Ruszkay N; Valentino W; Derkay CS; McClay JE; Bastian RW; Myer CM; Lollar KW; Guris D
PLoS One; 2020; 15(3):e0230106. PubMed ID: 32160246
[TBL] [Abstract][Full Text] [Related]
16. HPV vaccination as preventive approach for recurrent respiratory papillomatosis - a 22-year retrospective clinical analysis.
Mauz PS; Schäfer FA; Iftner T; Gonser P
BMC Infect Dis; 2018 Jul; 18(1):343. PubMed ID: 30041619
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
[TBL] [Abstract][Full Text] [Related]
18. Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis.
Tjon Pian Gi RE; San Giorgi MR; Pawlita M; Michel A; van Hemel BM; Schuuring EM; van den Heuvel ER; van der Laan BF; Dikkers FG
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3231-6. PubMed ID: 27188508
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of the use of human papillomavirus vaccine as adjuvant therapy for juvenile-onset recurrent respiratory papillomatosis.
Park I; Carbone S; Preciado D
Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111314. PubMed ID: 36116179
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of 2-Dose HPV Vaccine Series for Postpartum Women: An Open-Label, Nonrandomized, Noninferiority Trial.
Moss CF; Wang R; Sao S; Chou B; Perin J; Lander ME; Thaker SM; Mann M; Coleman JS
JAMA Netw Open; 2024 Jan; 7(1):e2352996. PubMed ID: 38285445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
